TrialClinical pharmacokinetics2011

Effect of cytochrome P450 3A4 inducers on the pharmacokinetic, pharmacodynamic and safety profiles of bortezomib in patients with multiple myeloma or non-Hodgkin's lymphoma.

Andrzej Hellmann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.